Last year, antidepressant prescriptions in England reached a record 9.1 million patients.. This increase reflects a growing mental health crisis, with a particularly sharp rise in prescriptions for children and those in impoverished areas.
The 9.1 million patient milestone and the 21% surge in prescriptions
England has seen a significant escalation in the use of mood-regulating medication, with one in seven people receiving prescriptions last year. According to the NHS Business Services Authority, approximately 96 million antidepressant prescription items were dispensed in the last 12 months, representing a 21 per cent increase from the 79.4 million items handed out five years prior.
The volume of patients receiving these drugs has grown by more than 15 per cent over the same five-year window. this trend suggests a systemic shift in how primary care manages mental distress across the English population, moving toward a higher reliance on pharmaceutical intervention.
Why North Cumbria and South Yorkshire lead the prescription rates
The distribution of mental health medication is not uniform across England, revealing a deep correlation between economic hardship and chemical treatment. patients treated under the North East and North Cumbria Integrated Care Board showed the highest rates of use, with 200 out of every 1,000 people prescribed antidepressants. This is nearly double the rate found in the more affluent districts of London.
The divide is further highlighted by the fact that England's most deprived communities received roughly a third more prescriptions than the least disadvantaged areas. This disparity suggests that medication is being used more frequently in regions where social safety nets may be thinner or environmental stressors are higher.
The 65% female majority and the rise in child prescriptions
Gender and age play critical roles in the current prescription data. Women accounted for 65 per cent of all patients last year, totaling 5.9 million individuals. While women are twice as likely as men to be diagnosed with depression, experts remain divided on whether this gap is driven by biological differences or a greater willingness among women to seek clinical help.
Perhaps more concerning is the trend among minors. prescriptions for children rose for the first time in four years, increasing from 62,601 in 2024/25 to 63,609 last year. By 2023, one in five children aged eight to 16 suffered from a probable mental disorder, up from one in six in 2020. This rise occurs despite warnings that these drugs can increase suicidal thoughts in young people, and despite National Institute for Health and Care Excellence (NICE) guidelines stating that medication for under-18s should only follow a specialist assessment and be paired with psychological therapy.
20.5 million lost working days and the 120% rise in sertraline use
The mental health crisis is exerting a heavy toll on the English economy. As reported by the Office for National Statistics (ONS), approximately 20.5 million working days were lost to poor mental health in 2024. Furthermore, 1.35 million working-age individuals who were out of work due to long-term sickness reported suffering from anxiety or depression in 2023, a 40 per cent increase compared to pre-pandemic levels.
This broader societal stress is mirrored in the specific drugs being prescribed. Sertraline, a common selective serotonin reuptake inhibitor (SSRI), has seen a 120 per cent increase in prescriptions over the last decade. Professor Dame Clare Gerada, former chairman of the Royal College of General Practitioners, argues that these numbers reflect a society that is more stressed and anxious than ever before,rather than a failure of medical practice.
Dr. John Read's 'epidemic of overprescribing' versus clinical necessity
A sharp debate has emerged regarding whether these figures represent a genuine medical need or a failure of social support. Dr. John Read, a professor of clinical psychology at the University of East London, characterizes the current trend as an "epidemic of overprescribing," suggesting that GPs are being pressured to treat social and life problems with medication rather than addressing the root causes of distress.
Several critical questions remain unanswered by the current data. It is unclear how many patients are staying on antidepressants longer than NICE guidelines recommend, or how many are receiving the recommended psychological therapies alongside their medication.. Additionally, the data does not specify if the rise in prescriptions is accompanied by a corresponding increase in the availability of non-pharmaceutical mental health services in the most deprived regions.
Comments 0